Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will evaluate the differences in cardiovascular parameters between women with severe preterm preeclampsia and those without preeclampsia using echocardiography and maternal blood. The investigators will also look at associations of abnormal cardiovascular findings and immediate complications among a high risk cohort of pregnant African American women.
This will be a prospective cohort study. Exposed cases will be admitted to the inpatient obstetrical unit (labor & delivery or antepartum unit) at the Hospital of the University of Pennsylvania with concern for severe preterm preeclampsia. Unexposed controls will be matched by gestational age and other clinical factors and will be obtained from the outpatient setting (Helen O Dickens clinic or Penn ObGyn Associates at 3701 Market Street). The investigators will compare cardiovascular risk factors between these two groups.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exposed cases | African American women with concern for severe preterm (37 weeks gestation) preeclampsia who are admitted to the inpatient obstetrical unit at HUP. | ||
| Unexposed controls | African American women without preeclampsia or medical comorbidity who are matched by gestational age, maternal age, and BMI in the outpatient setting. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Cardiovascular parameters obtained on echocardiogram (longitudinal strain and E/E) | 2 years | |
| Angiogenic factors and biomarkers of congestive heart failure (sFlt1) | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Other cardiovascular parameters measured on echocardiogram (ventricular arterial coupling, arterial tonometry) | 2 years | |
| Other angiogenic factors and biomarkers of CHF (VEGF, BNP, troponin, etc) | 2 years |
Not provided
Exposed cases:
Inclusion Criteria:
Exclusion Criteria:
Unexposed controls:
Inclusion Criteria:
Exclusion Criteria:
Non-African American women and women who are not receiving care at our institution.
Not provided
Not provided
This study will take place on the obstetrical unit at the Hospital of the University of Pennsylvania (HUP) as well as in the outpatient setting. The patient population is primary from the surrounding urban region. The majority receive prenatal care at our institution. Based on fiscal year 2010 at HUP, the mean age was 24 years old and 85% were African American.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lisa Levine, MD | UENN | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States |
Not provided
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of angiogenic factors, markers of heart failure, and evaluation of extracellular RNAs will specifically be used for discovery. The investigators will not be evaluating DNA.
| Postpartum readmission rate | 2 years |
| Pulmonary edema during labor and delivery or postpartum | 2 years |
| Peripartum cardiomyopathy | 2 years |